Saturday, May 28, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia

by Medical Finance
in Coronavirus
Study: Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021. Image Credit: Lightspring/Shutterstock
9
SHARES
100
VIEWS
Share on FacebookShare on Twitter

To prevent the further spread of coronavirus disease-19 (COVID-19) infection, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), most countries worldwide implemented travel restrictions. Researchers conducted epidemiologic and genomic studies to investigate in-flight SARS-CoV-2 infection associated with repatriation flights from India to Australia in April 2021. This study has been published as a research letter in Emerging Infectious Diseases.

Study: Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021. Image Credit: Lightspring/Shutterstock
Study: Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021. Image Credit: Lightspring/Shutterstock

Background

The Australian government closed down its borders during the first SARS-CoV-2 epidemic wave. All international arriving passengers were required to follow mandatory supervised quarantine during this period. The first pandemic wave lasted till June 2020 in Australia. 

In October 2020, a quarantine facility in Darwin, Northern Territory, Australia, received individuals who arrived via government-assisted repatriation flights. Researchers stated that two repatriation flights landed in Darwin on April 15 and 17, 2021, which were named flights 1 and 2, carrying passengers from two regions of India experiencing a major COVID-19 outbreak.

Scientists observed that compared to previous repatriation flights that landed in Darwin between October 2020 and April 2021, flights 1 and 2 carried a significantly higher percentage of COVID-19 positive individuals.

All passengers traveling on these flights tested negative for SARS-CoV-2 by quantitative reverse transcription PCR (qRT-PCR) within 48 hours before flying. Furthermore, wearing face masks was mandatory for all passengers except infants and children. During the study period, COVID-19 vaccination coverage among passengers was low, i.e., 7% of the passengers had received the first dose of the vaccine, and only fourteen passengers out of the total of 345 passengers received two doses of COVID-19 vaccine. When they arrived in Darwin, all passengers underwent supervised quarantine where they were tested for SARS-CoV-2 via the qRT-PCR method on days zero, seven, and twelve. 

Key findings

Among the forty-seven passengers who tested SARS-CoV-2 positive, twenty-one tested positive on arrival (arrival case-patients), and twenty-six tested positive after a day of entering quarantine in Darwin (quarantine case-patients). Scientists reported that among the twenty-one-arrival case-patients, eighteen were asymptomatic. The qRT-PCR cycle threshold values of 86% of this group were 15.2. However, for quarantine case-patients median time of symptom onset was 5 days after arrival.

Researchers conducted genomic sequencing for 87% of SARS-CoV-2-positive passengers. They reported that 57% of passengers were infected with Delta variant, 21% with Kappa, 6% with Alpha, and 2% of passengers were infected with A.23.1 sublineage of SARS-CoV-2. Additionally, 59% of the SARS-CoV-2 positive sequence of the two flights belonged to one of six genomic clusters.

To assess if the passengers contracted the infection during the flight, researchers analyzed case interviews, flight manifests and performed genomic sequencing. Out of twenty-one arrival case-patients, four passengers identified as B, J, O, and T possibly transmitted the SARS-CoV-2 infection to more than eleven other passengers. The samples from these eleven passengers were sequenced and were found to belong to the same SARS-CoV-2 genomic clusters of B, J, O, and T. These passengers were seated in two rows of an arrival case-patient.

Scientists also estimated the secondary attack rates to be 6% for flight 1 and 2% for flight 2. They further observed that five case-patients were linked genomically. Hence, there was a high possibility that transmission had occurred before, during, or after the flight. Genomics refuted transmission to six quarantine case-patients seated within two rows of an arrival case-patient, connecting three to a different cluster.

Implications

After these two repatriation flights, other repatriation flights from India were suspended. However, flights resumed on May 15, 2021, and a mandatory 72-hour pre-flight quarantine of passengers within India was implemented. Two of the factors that contributed to a reduction in the repatriation cases were an increased vaccination rate and a decrease in the Delta wave in India and globally. The authors of this study emphasized that COVID-19 vaccination rates in Australia were low during the study period and quarantine was a vital part of reducing international incursions. 

Researchers further indicated they did not exclude the possibility of transmission of the virus in the departure lounge and during boarding. The main strength of this study is the inclusion of complete pre-flight and post-flight testing and genomic sequencing. It provided strong evidence of in-flight associated SARS-CoV-2 transmission, based on two repatriation flights from India to Australia during the Delta variant wave in April 2021.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Low risk of SARS-CoV-2 transmission by fomites – a clinical observational study in highly infectious COVID-19 patients. Image Credit: David Pereiras/Shutterstock

Transmission of infectious SARS-CoV-2 via fomites is possible but unlikely to occur in real-life scenarios, study concludes

by Medical Finance
May 28, 2022
0

Fomites are droplet-contaminated surfaces that may play a role in the transmission of coronavirus disease 2019 (COVID-19). Early during the...

Study: Maternal and perinatal outcomes in pregnant women with SARS-CoV-2 infection: a retrospective observational study. Image Credit: Velishchuk Yevhen/Shutterstock

Impact of SARS-CoV-2 infection in pregnant women on maternal and perinatal outcomes

by Medical Finance
May 27, 2022
0

In a study posted to the preprint server Research Square*, researchers conducted a retrospective cohort analysis by reviewing medical...

Menstrual Cycle

Do COVID-19 vaccinations increase the length of the menstrual cycle?

by Medical Finance
May 27, 2022
0

In this interview, we speak to Professor Alison Edelman about her latest research that investigated the effects COVID-19 vaccinations have...

Study: Protection against omicron severe disease 0-7 months after BNT162b2 booster. Image Credit: peterschreiber.media/Shutterstock

Effectiveness of BNT162b2 third dose against Omicron-associated severe disease

by Medical Finance
May 27, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers analyzed the effectiveness of the severe acute respiratory syndrome coronavirus...

Study: In silico analysis of predicted differential MHC binding and CD8+ T-cell immune escape of SARS-CoV-2 B.1.1.529 variant mutant epitopes. Image Credit: Fit Ztudio/Shutterstock

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

by Medical Finance
May 27, 2022
0

In a recent study posted to the bioRxiv* pre-print server, a team of researchers assessed the affinity of the severe...

Study: Public health impact of covid-19 vaccines in the US: observational study. Image Credit: Prostock-studio/Shutterstock

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

by Medical Finance
May 27, 2022
0

By using data representing 80% of the US population, researchers have found that increased vaccination coverage against coronavirus disease 2019...

Next Post
First patient-derived stem cell model developed for studying oculocutaneous albinism

New training scheme for convolutional neural networks automates cell segmentation and counting

Scientists identify a new switch for controlling motor proteins

Scientists discover how immune proteins defend plants against invading microorganisms

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study. Image Credit: triocean/Shutterstock
    Safety and immunogenicity of high-dose quadrivalent influenza vaccine and mRNA-1273 vaccine booster in older adults
  • Study: Removal of Clinically Relevant SARS-CoV-2 Variants by An Affinity Resin Containing Galanthus nivalis Agglutinin. Image Credit: Lightspring/Shutterstock
    Efficacy of affinity resin containing Galanthus nivalis agglutinin against SARS-CoV-2
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply